The genomic landscape of endocrine-resistant metastatic breast cancer

被引：0
|
作者：
Razavi, P. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-ES4-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES4-3
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
    Bahnassy, Shaymaa
    Thangavel, Hariprasad
    Quttina, Maram
    Khan, Ashfia Fatima
    Dhanyalayam, Dhanya
    Ritho, Joan
    Karami, Samaneh
    Ren, Jing
    Bawa-Khalfe, Tasneem
    CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
  • [32] Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer
    Chen, Jing
    Wan, Runlan
    Li, Qinqin
    Rao, Zhenghuan
    Wang, Yanlin
    Zhang, Lei
    Teichmann, Alexander Tobias
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [33] The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?
    Migliaccio, I.
    Biganzoli, L.
    Malorni, L.
    ANNALS OF ONCOLOGY, 2024, 35 (08) : 683 - 685
  • [34] Genomic alterations indicative of a lumina! A subtype associate with clinical benefit to buparlisib and letrozole in endocrine-resistant ER+/HER2 metastatic breast cancer
    Balko, J. M.
    Hicks, M.
    Berger, M. F.
    Solit, D. B.
    Bouvier, N.
    Sanders, M. E.
    Estrada, M. V.
    Won, H.
    Cantley, L. C.
    Mayer, I. A.
    Arteaga, C. L.
    CANCER RESEARCH, 2016, 76
  • [35] Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER plus metastatic breast cancer
    Haddad, Tufia C.
    D'Assoro, Antonino
    Suman, Vera
    Opyrchal, Mateusz
    Peethambaram, Prema
    Liu, Minetta C.
    Goetz, Matthew P.
    Ingle, James N.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 639 - 647
  • [36] Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer
    Stone, Andrew
    Valdes-Mora, Fatima
    Clark, Susan J.
    EPIGENOMICS, 2013, 5 (06) : 595 - 598
  • [37] Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches
    Shete, Nivida
    Calabrese, Jordan
    Tonetti, Debra A.
    CANCERS, 2023, 15 (14)
  • [38] Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer
    Jing Chen
    Runlan Wan
    Qinqin Li
    Zhenghuan Rao
    Yanlin Wang
    Lei Zhang
    Alexander Tobias Teichmann
    Cancer Cell International, 21
  • [39] New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
    Kennedy, Laura C.
    Mayer, Ingrid A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 511 - 521
  • [40] MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells
    Petri, Belinda J.
    Piell, Kellianne M.
    Wilt, Ali E.
    Howser, Alexa D.
    Winkler, Laura
    Whitworth, Mattie R.
    Valdes, Bailey L.
    Lehman, Norman L.
    Clem, Brian F.
    Klinge, Carolyn M.
    ENDOCRINE-RELATED CANCER, 2023, 30 (11)
12345